Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Average Rating of “Moderate Buy” by Brokerages
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average twelve-month price objective […]
More Stories
SingularityNET 24 Hour Volume Hits $60,508.45 (AGIX)
SingularityNET (AGIX) traded down 3.1% against the dollar during the 24-hour period ending at 8:00 AM Eastern on December 28th....
ECOMI (OMI) Self Reported Market Capitalization Tops $105.35 Million
ECOMI (OMI) traded 6% lower against the U.S. dollar during the twenty-four hour period ending at 8:00 AM E.T. on...
Short Interest in AOT Growth & Innovation ETF (NASDAQ:AOTG) Rises By 300.0%
AOT Growth & Innovation ETF (NASDAQ:AOTG – Get Free Report) saw a significant increase in short interest during the month...
Sable Resources (CVE:SAE) Stock Price Down 16.7% – What’s Next?
Sable Resources Ltd. (CVE:SAE – Get Free Report)’s stock price was down 16.7% on Saturday . The stock traded as...
Short Interest in Allot Communications Ltd (NASDAQ:ALLT) Grows By 30.1%
Allot Communications Ltd (NASDAQ:ALLT – Get Free Report) was the target of a significant growth in short interest during the...
American Lithium Corp. (NASDAQ:AMLI) Sees Large Growth in Short Interest
American Lithium Corp. (NASDAQ:AMLI – Get Free Report) saw a significant growth in short interest in the month of December....